Answer
Jul 31, 2025 - 09:44 AM
The FDA Boxed Warning indicates that severe acute worsening of hepatitis B can occur in patients coinfected with HIV-1 and HBV who stop taking products containing emtricitabine and/or tenofovir disoproxil fumarate, including this medication. Monitoring liver function is essential for patients with hepatitis B to prevent severe liver complications.
